List view / Grid view

Novartis

Novartis drug Galvus® approved in EU

5 December 2011 | By Novartis

The European Commission has approved Galvus® (vildagliptin) (50 mg once a day) for the treatment of type 2 diabetes patients with moderate or severe renal impairment...

news

Novartis highlights advances for patients with cancers and hematological diseases

2 December 2011 | By Novartis

Novartis will showcase more than 160 presentations on data from its robust oncology portfolio...

news

Novartis gains European Commission approval for Rasitrio®

28 November 2011 | By Novartis

Rasitrio®, the first triple combination of aliskiren, amlodipine and hydrochlorothiazide in a single pill has received approval...

news

Novartis and collaborators discover new dual-acting class of antimalarial compounds with potential to both prevent and treat malaria infections

17 November 2011 | By Novartis

Discovery of a new class of dual-acting antimalarial compounds...

news

Novartis appoints Timothy Wright, M.D. as Global Head, Development, Novartis Pharmaceuticals

9 November 2011 | By Novartis

Novartis announced the appointment of Timothy Wright...

news

Novartis Phase III study shows ACZ885 helped substantially reduce steroid use in 45% of patients with serious form of childhood arthritis

7 November 2011 | By Novartis

New pivotal Phase III data announced...

news

Novartis Phase II data show AIN457 provided rapid and significant relief of symptoms in up to 81% of patients with psoriasis

24 October 2011 | By Novartis

Positive results from three Phase II trials...

news

Novartis drug Gilenya® (fingolimod) shows up to 71% reduction in annualized relapse rates in MS patients

17 October 2011 | By Novartis

Novartis will showcase data from 13 abstracts on fingolimod (Gilenya®)...

news

Novartis receives approval in Japan for two innovative therapies, Gilenya® in MS and Ilaris® in CAPS

27 September 2011 | By Novartis

Novartis has received regulatory approval in Japan for once-daily Gilenya (fingolimod)...

news

New data shows potential of respiratory portfolio to help COPD patients maintain active and productive lives

27 September 2011 | By Novartis

Novartis has presented new Phase III data at the ERS congress...

news

Afinitor® helps women with advanced breast cancer live longer without their disease progressing

26 September 2011 | By Novartis

Afinitor® more than doubled the time women lived without tumor growth...

news

Novartis gains positive CHMP opinion for Rasitrio®

23 September 2011 | By Novartis

The CHMP adopted a positive opinion for Rasitrio® for the treatment of high blood pressure...

news

Novartis drug Afinitor® effective in patients with non-cancerous kidney tumors associated with TSC in Phase III trial

23 September 2011 | By Novartis

A Phase III study of Afinitor® (everolimus) tablets* met its primary endpoint of best overall angiomyolipoma response rate...

news

Novartis increases growth potential through integration of Alcon

13 September 2011 | By Novartis

Alcon to accelerate growth through Novartis strength in market access, reimbursement, and research capability...

news

Novartis receives EU approval for Votubia®

8 September 2011 | By Novartis

The European Commission has approved Votubia® (everolimus) tablets* for the treatment of patients aged 3 years and older...

Cookie	Description
cookielawinfo-checkbox-advertising-targeting	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Description
cf_ob_info	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	This cookie is set by Youtube and is used to track the views of embedded videos.

Cookie	Description
bcookie	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	This cookie is set by LinkedIn and used for routing.
lissc	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Description
advanced_ads_browser_width	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Recommended

Novartis